Nippon India Pharma Fund vs ITI Pharma and Healthcare Fund Regular compare
ITI Pharma and Healthcare Fund Regular - Growth
Nippon India Pharma Fund-Growth Plan-Growth Option
Chart Comparison
Overview
Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | Nippon India Pharma Fund-Growth Plan-Growth Option |
---|---|---|
Fund | ITI Pharma and Healthcare Fund Regular - Growth | Nippon India Pharma Fund-Growth Plan-Growth Option |
Investment Plan | Growth | Growth |
Level of Risk | Very High | Very High |
Asset Size (Cr) | ₹230 Cr | ₹8569 Cr |
Min Investment | ₹5000 | ₹5000 |
Min SIP Invesment | ₹500 | ₹500 |
Min Addl Investment | ₹1000 | ₹1000 |
Launch Date | 08 Nov 2021 | 05 Jun 2004 |
Category | Pharma & Healthcare | Pharma & Healthcare |
Fund Type | Open Ended | Open Ended |
Benchmark | NIFTY Healthcare TRI | BSE Healthcare |
Turn Over | % | 21% |
Expense Ratio | 2.35 | 1.82 |
Manager | Rohan Korde | Sailesh Raj Bhan |
ISIN Code | INF00XX01BL5 | INF204K01968 |
Exits Load | ITI Pharma & Healthcare Fund - Regular Plan - Growth charges 1.0% of sell value; if fund sold before 365 days. There are no other charges./365 | Nippon India Pharma Fund - Growth charges 1.0% of sell value; if fund sold before 30 days. There are no other charges./365 |
Trailing Lumpsum Returns
Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | Nippon India Pharma Fund-Growth Plan-Growth Option |
---|---|---|
1 Month | 2.92% | 3.45% |
6 Month | 6.83% | 12.02% |
1 Year | 9.37% | 10.9% |
3 Year | 22.5% | 24.95% |
5 Year | - | 21.24% |
SIP Return Analysis
Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | Nippon India Pharma Fund-Growth Plan-Growth Option |
---|---|---|
6 Month | 6.17% | 7.77% |
1 Year | 6.47% | 12.61% |
3 Year | 23.21% | 25.2% |
5 Year | - | 20.43% |
Rolling Lumpsum Returns
Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | Nippon India Pharma Fund-Growth Plan-Growth Option |
---|---|---|
1 Year | 20.48% | 17.67% |
3 Year | 18.71% | 20.32% |
5 Year | - | 20.52% |
Risk Management
Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | Nippon India Pharma Fund-Growth Plan-Growth Option |
---|---|---|
Standard Deviation | 15.42% | 14.75% |
Sharp | 1.06% | 1.20% |
Beta | 0.95% | 0.90% |
Alpha | -1.54% | 0.72% |
Still Confused Which Fund To Select? Don’t worry! We’re just a call away.
Get Free Experts Guidance
Fund Managers
Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | Nippon India Pharma Fund-Growth Plan-Growth Option |
---|---|---|
Name | Rohan Korde | Sailesh Raj Bhan |
Total AUM | ₹4626 Cr | ₹96086 Cr |
Funds Managed | 10 | 5 |
ITI Pharma and Healthcare Fund Regular - Growth | Nippon India Pharma Fund-Growth Plan-Growth Option |
Market Cap
Scheme Name |
ITI Pharma and Healthcare Fund Regular - Growth |
Nippon India Pharma Fund-Growth Plan-Growth Option |
---|---|---|
Others | 3.93 | 0.53 |
Mid Cap | 35.23 | 31.99 |
Small Cap | 33.57 | 32.41 |
Large Cap | 27.27 | 35.06 |
Sector Allocation
Scheme Name |
ITI Pharma and Healthcare Fund Regular - Growth |
Nippon India Pharma Fund-Growth Plan-Growth Option |
---|---|---|
Others | 2.74 | 0.53 |
Healthcare | 92.05 | 99.47 |
Basic Materials | 4.2 | - |
Industrials | 1.01 | - |
Top Comparisons
UTI ANNUAL INTERVAL FUND II REGULAR PLAN GROWTH
3Y Returns6.26%
UTI ANNUAL INTERVAL FUND II REGULAR PLAN GROWTH
3Y Returns6.26%
Invesco India Smallcap Fund - Regular Plan - Growth
3Y Returns26.95%
UTI Small Cap Fund - Regular Plan - Growth Option
3Y Returns20.53%
HDFC Flexi Cap Fund - Growth Plan
3Y Returns23.44%
SBI Flexicap Fund - REGULAR PLAN -Growth Option
3Y Returns13.42%
Sundaram Liquid Fund (G)
3Y Returns6.94%
360 ONE Liquid Fund Regular-Growth
3Y Returns6.83%